Market Trends of Europe Fetal and Neonatal Monitoring Industry
This section covers the major market trends shaping the Europe Fetal & Neonatal Monitoring Market according to our research experts:
Pulse Oximeters Segment is Expected to Hold Significant Share in the Market Over the Forecast Period
A pulse oximeter is a device that is used to estimate the oxygen saturation of the blood and pulse rate in neonates. Pulse Oximetry screening is done after 24 hours after birth to allow the baby's heart and lungs to fully adjust to life outside the birth mother. This is a vital instrument in the care of infants and children with cardio-pulmonary disease. Factors such as the high burden of diseases among neonates and the growing demand for early diagnosis are also expected to drive the growth of the studied segment. For instance, as per the NCBI article published in April 2022, neonatal screening in Germany currently comprises 19 congenital diseases, 13 of which are metabolic diseases. Approximately 1300 newborns suffer from one of these target diseases. Therefore, the high risk of diseases in neonatal and the incidence of preterm births in the region is boosting the segment growth.
The increasing awareness and advanced product launches in this region are anticipated to boost segment growth over the forecast period. For instance, in November 2021, Masimo launched the Dual SET pulse oximetry for root, a versatile patient monitoring and connectivity hub. The first application of Dual SET oximetry is a significant advancement for critical congenital heart disease in newborns. Additionally, in February 2021, Medtronic plc completed its study on Newborns using Nellcor Pulse Oximetry Technology and revealed that a stable signal was obtained from all 60 newborns with the Nellcor pulse oximeter, thus suggesting this device is a simple, noninvasive bedside monitoring device for neonates in the detection of oxygen saturation levels and heart rate. Thus, owing to the aforementioned factors, rising demand for pulse oximeters, and the launch of advanced products, the studied segment is expected to register a notable CAGR over the forecast period in the region.
United Kingdom is Expected to Hold the Significant Share in the Market Over the Forecast Period
The United Kingdom is expected to hold a significant share in the Europe fetal and neonatal monitoring market over the forecast period owing to the rising number of births and favorable government policies, and increasing awareness campaigns regarding neonatal healthcare. For instance, according to the Office for National Statistics data published in 2022, there were 625,008 live births in 2021, an increase of 1.5% from 615,557 live births in 2020. Such an increase in birth is expected to boost the demand for fetal and neonatal monitoring systems in the United Kingdom.
Moreover, the rising number of favorable policies for fetal and neonatal care and awareness campaigns in the United Kingdom are expected to fuel the growth of the market in this country. For instance, in September 2022, Dentsu UK&I launched a dedicated policy designed to support parents of babies born prematurely or critically ill and receiving neonatal care in the hospital, enabling them to spend more time together. Also, in September 2021, a Neonatal Intensive Care Unit awareness campaign was conducted in the United Kingdom to raise awareness of neonatal care and support impacted families. Hence, owing to the aforementioned factors, such increase in the birth rate and favorable policies, the studied market is expected to witness growth over the forecast period in the region.
